Latest Morning Briefing Stories
Decisión de Eli Lilly de bajar el precio de su insulina logrará cambios históricos en los costos
Expertos en precios de medicamentos celebraron la noticia de Eli Lilly y otros esfuerzos. Y estas otras iniciativas para llevar al mercado insulina de menor costo, a su vez, presionarían a Eli Lilly para que mantuviera sus precios bajos.
KFF Health News' 'What the Health?': March Medicaid Madness
President Joe Biden and Republicans in Congress spent last month sparring over whether to shield Medicare and Social Security from budget cuts — leading some to wonder if Medicaid was on the table instead. Biden and Democrats say no, but some Republicans seem eager to trim federal spending on the health program for Americans with low incomes. And ready or not, artificial intelligence is coming to medical care. Benefits, as well as unintended consequences, are likely. Alice Miranda Ollstein of Politico, Rachel Cohrs of STAT News, and Lauren Weber of The Washington Post join KHN’s chief Washington correspondent, Julie Rovner, to discuss these issues and more.
Eli Lilly Slashed Insulin Prices. This Starts a Race to the Bottom.
Eli Lilly’s news that it plans to cut insulin costs for patients will help, not hinder, the recent efforts in California and by entrepreneurs such as Mark Cuban to offer lower-cost alternatives, drug pricing experts said.
Watch: Dental Device at Center of Lawsuits Was Used on Patients Without FDA Review
More than 10,000 dental patients have been fitted with an Anterior Growth Guidance Appliance, or AGGA, according to court records. But the unproven and unregulated device has not been evaluated by the FDA, according to a months-long joint investigation by KHN and CBS News.
After People on Medicaid Die, Some States Aggressively Seek Repayment From Their Estates
States take drastically different approaches to recovering Medicaid money from deceased participants’ estates. Demands for repayment of Medicaid spending can drain the assets a person leaves behind, depending on where they lived.
California’s Massive Medicaid Program Works for Some, but Fails Many Others
Medi-Cal serves more than one-third of the state’s population — offering a dizzying range of care to a diverse population. In the new “Faces of Medi-Cal” series, California Healthline will assess the program’s strengths and weaknesses through the lives and experiences of its enrollees.
This Dental Device Was Sold to Fix Patients’ Jaws. Lawsuits Claim It Wrecked Their Teeth.
A dental device called AGGA has been used on about 10,000 patients without FDA approval or proof that it works. In lawsuits, patients report irreparable harm. The AGGA’s inventor and manufacturer have denied all liability in court.
Biden Promises to Fight GOP on ‘Gutting’ Medicaid. Budget Talks Seem Like Another Story.
As many lower-income Americans prepare to lose pandemic-era access to Medicaid, President Joe Biden vowed to stop Republicans from making deeper cuts to lower the national debt. Other changes may still be up for discussion.
Surprise-Billing Law Loophole: When ‘Out of Network’ Doesn’t Quite Mean Out of Network
Billing experts and lawmakers are playing catch-up as providers find ways to get around new surprise-billing laws, leaving patients like Danielle Laskey of Washington state with big bills for emergency care.
After Capping Insulin Copays, Colorado Sets Its Sights on EpiPens
Colorado’s proposed legislation to cap the copay for the EpiPen is part of a nationwide trend as more states try to shield patients from skyrocketing drug prices.
California dice que ya no puede costear las pruebas de covid ni las vacunas para los migrantes
El estado mantiene tres centros de recursos sanitarios —dos en el condado de San Diego y uno en el condado de Imperial— que realizan pruebas y vacunaciones contra covid y otros exámenes de salud, y han atendido a más de 300,000 migrantes desde abril de 2021.
California Says It Can No Longer Afford Aid for Covid Testing, Vaccinations for Migrants
Gov. Gavin Newsom is winding down state assistance for health care services to migrants seeking asylum. He’s lobbying the Biden administration to increase aid along the state’s southern border.
A Bitter Battle Over the ‘Orphan Drug’ Program Leaves Patients’ Pocketbooks at Risk
Patients who depend upon special drugs to treat rare diseases are caught in the crossfire as drugmakers and the FDA battle over regulations that reward companies for developing treatments for relatively small pools of patients.
Mark Cuban Has Been Taking On the Drug Industry. But Which One?
The billionaire entrepreneur and NBA team owner is making waves with his new drug company. But his generics aren’t always the lowest-priced deal.
An Arm and a Leg: She Sued a Hospital and Lost — But Felt She’d Won
A listener sued a hospital in small-claims court and lost but felt as if she’d won. Now, she wants to encourage more people to take their bills to court.
Armed With Hashtags, These Activists Made Insulin Prices a Presidential Talking Point
Twitter has been a hotbed for the burgeoning insulin access movement and activism surrounding other medical conditions. For people with diabetes, the platform has helped propel concern about insulin prices into policy. Can it continue to win with hashtags?
Watch: In Insurers’ Eyes, Not All Midwives Are Equal
The first installment of InvestigateTV and KHN’s “Costly Care” series explores one California mother’s experience struggling to get reimbursed for midwifery care and the differences between providers that may determine whether insurance covers them.
When Medicare stops paying for a pricey drug that prolongs life, an Ohio man considers giving up treatment to spare his family enormous debt.
Special Delivery: Heart-Heavy Health Policy Valentines
KHN shares the cream of the crop of creative valentines about health policy submitted by readers and tweeters. Our favorite is anointed with an original illustration and bragging rights as “the one.”
Doctors Are Disappearing From Emergency Rooms as Hospitals Look to Cut Costs
As a money-saving strategy, emergency rooms are turning to nurse practitioners, physician assistants, and other staffers who earn far less than physicians.
